Highly Potent Th1-Type NKT Cell Agonists as Immunotherapeutic Agents via Conformational Restriction Design

Yu Wen1, Ye-Hui Wu1, Qian-Nan Sun1

  • 1International Joint Research Center for Intelligent Biosensing Technology and Health, National Key Laboratory of Green Pesticide, College of Chemistry, Central China Normal University, Wuhan 430079, China.

JACS Au
|February 27, 2026
PubMed

Insights

New branched analogs of alpha-galactosylceramide (αGalCer) show potent Th1-biased natural killer T (NKT) cell activation. These novel agonists demonstrate enhanced anti-tumor efficacy and translational potential for immunotherapy.

Area of Science:

  • Immunology
  • Drug Discovery
  • Biochemistry

Background:

  • Natural killer T (NKT) cells are crucial for cellular immunity against tumors and pathogens.
  • Developing potent Th1-biased NKT cell agonists, like alpha-galactosylceramide (αGalCer), is critical for immunotherapy.
  • Previous structural modifications of αGalCer have yielded limited success in enhancing Th1-biased responses.

Purpose of the Study:

  • To design novel αGalCer analogs with restricted conformations for enhanced NKT cell agonism.
  • To investigate the immunotherapeutic potential of these new analogs.
  • To evaluate the efficacy of novel agonists against tumors.

Main Methods:

  • Conformational restriction strategy by replacing the linear acyl chain of αGalCer with branched motifs.
  • Design and synthesis of a series of αGalCer branched analogs.
  • In vivo assessment of Th1-biased responses (IFN-γ, IL-4) and anti-tumor efficacy in mice.
  • Evaluation of activity in human NKT cells.

Main Results:

  • Two optimized candidates, GCB-27a and GCB-27b, demonstrated significantly enhanced Th1-biased responses compared to αGalCer.
  • These novel agonists induced over 10-fold higher IFN-γ levels with limited IL-4 production.
  • GCB-27a and GCB-27b exhibited superior anti-tumor efficacy in mouse models.
  • The agonists retained significant activity in human NKT cells.

Conclusions:

  • The conformational restriction strategy successfully generated potent Th1-biased NKT cell agonists.
  • GCB-27a and GCB-27b represent promising immunotherapeutic agents with translational potential.
  • These findings offer a new avenue for developing effective NKT cell-based immunotherapies.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K